Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VEN307 in Anal Fissure
NCT01690221Phase 3Completed
- Sponsor
- Ventrus Biosciences, Inc.
- Start
- Oct 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of DOLIZEM in anal fissure, sponsored by Ventrus Biosciences, Inc.. Started Oct 2012; status: completed.
02
Drugs
DOLIZEM
03
Conditions
anal fissure
Beyond the preview
Go deeper on NCT01690221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01690221.